NCT05933395
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05933395 |
| Title | Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor (GERTRUDE) |
| Acronym | GERTRUDE |
| Recruitment | Recruiting |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Dartmouth-Hitchcock Medical Center |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
CKB BOOST